Blog - Page 4549 of 5482

WednesdayApr 16, 2008 1:31 pm

AVI BioPhama, Inc. (AVII) Appoints Dr. Ryszard Kole as Senior Vice President of Discovery Research

AVI announced the appointment of Dr. Ryszard Kole, PhD, a pioneer in the use of oligonucleotides for the modulation of splicing, as Senior Vice President of Discovery Research. Dr. Kole has a successful history in the research and discovery of directed alternative splicing. He received his PhD from the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences. After joining the Department of Pharmacology at the University of North Carolina at Chapel Hill as a faculty member, Dr. Kole's efforts led to a breakthrough demonstrating that splicing provides a novel target for gene-based therapies for numerous disorders including…

WednesdayApr 16, 2008 1:09 pm

Hybrid Technologies, Inc. (HYBR.OB) is "One to Watch"

Hybrid Technologies, Inc. (HYBR.OB) is committed to using its resources for the development and marketing of lithium-powered products which can operate vehicles, commercial buildings and residential homes. The company has successfully converted scooters, bicycles, mopeds, motorcycles, cars and homes into zero-emission, lithium-powered vehicles and facilities. The company’s products have received massive attention from CNN, Forbes, Popular Mechanics, Wired magazine and other media sources. Marketing trend forecasters believe that the company's all-lithium BMW AG Mini Cooper will become the new “it” car among the Hollywood crowd, who are no strangers to the company. Because Hybrid Technologies’ vehicles are not run on…

WednesdayApr 16, 2008 12:21 pm

Novavax Inc. (NVAX) Announces Results for Seasonal Influenza Vaccine Candidate

Novavax Inc. (Nasdaq: NVAX) today announced positive results from its immunogenicity study in ferrets inoculated with the company’s seasonal influenza vaccine candidate. The results allow Novavax to complete its new investigational drug application in support of Phase II clinical trials in the third quarter of this year. "Novavax' influenza programs are moving forward rapidly as planned," Dr. Penny Heaton, Novavax' Chief Medical Officer and vice president of Development stated in the press release. "In addition to the positive results from our seasonal influenza vaccine candidate announced today, the dose-ranging study of our H5N1 pandemic flu vaccine is enrolling as projected…

WednesdayApr 16, 2008 12:14 pm

Rudy Nutrition (RUNU.PK) Makes All the Right Moves; Up 23.5% During Intraday Trading

Rudy Nutrition, founded by sports legend Daniel "Rudy" Ruettiger, announced today that an agreement has been reached between itself and Collins Brothers, Inc. One of the country’s largest distributors of non-alcoholic products sold in liquor departments, Collins Brothers has been manufacturing well-known names such as V8 and Angostura Drink Mixes for over seventy years. This strategic alliance will offer Rudy Nutrition a chance to get its products noticed by millions, thereby providing the company with as yet unparalleled exposure. This is only one of the recent measures taken by Rudy Nutrition to increase brand-recognition in several states. On April 8th,…

WednesdayApr 16, 2008 11:51 am

Small Cap Voice Featured Client: Mantra Venture Group, Ltd. (MVTG.OB)

Mantra Venture Group, Ltd. (MVTG.OB) provides people and businesses the means to achieve reduction in their energy consumption and associated environmental impact. Mantra is active in the green technology market through its subsidiaries, which are focused on sustaining energy and reducing carbon emissions. The company operates in the United States and Canada with offices in Seattle, Washington and Vancouver, B.C. Mantra’s companies include Carbon Commodity Corp., Climate ESCO Ltd., Mantra Media Corp., Mantra Wind, Inc., and Mantra Energy. The company is engaged in providing multiple products and services through these subsidiaries. In addition, the company owns technology for the electrochemical…

WednesdayApr 16, 2008 11:45 am

Beacon Equity Research Featured Client: OmniaLuo, Inc. (OLUO.OB)

OmniaLuo, Inc. (OLUO.OB) designs, develops, markets and distributes women’s apparel under the brand name OMNIALUO. The company has a network of more than 211 retail stores across the People’s Republic of China and is based in China’s fashion capital of Shenzhen. OmniaLuo’s target customer base includes women between the ages of 25 and 35 with annual net incomes between $2,500 to $22,500. The company’s apparel line includes business casual women’s wear, such as slacks, tops, outerwear and accessories. The China Fashion Designers Association has recognized the OMNIALUO brand as “China’s Best Women’s Wear Design” from 2002-2006. OmniaLuo’s designs are marketed…

WednesdayApr 16, 2008 11:40 am

Nascent Foodservice, Inc. (NCTW.OB) Announces Fourth Quarter and Full Year 2007 Results

Nascent Wine Co Inc. (dba Nascent Foodservice) reported its fourth quarter and full year results ended December 31, 2007, as well as 2008 growth opportunities. Highlights of 2007 included: the addition of 4,700 employees; the addition of more than 6,800 new retail accounts, including Wal-Mart, Sam’s Club, Costco, HEB, Soriana, Gigante, Smart and Final; an expanded private label / proprietary product line totaling more than 200 items; and the completion of three major acquisitions. Commenting on the results, Sandro Piancone, CEO of Nascent Foodservice, stated, “We entered 2007 with a goal of expanding our platform to market and distribute food…

WednesdayApr 16, 2008 10:19 am

Luxury Goods Market Grows In China

The focus on China’s ongoing economic growth story has been mostly centered on the expansion of capitalism and opportunities for China’s growing middle class, but there is also a growing upper class in China with an appetite for luxury goods. Everything from luxury cars and high-end luggage to clothing has emerging market potential for these newly-affluent Chinese, along with an influx of goods and services for the burgeoning middle class. In the apparel area, one small company, Omnialuo (OTC: OLOU) is carving out a presence. Omnialuo - headed by founder and CEO Zheng “Cindy” Luo, an award winning chief designer…

WednesdayApr 16, 2008 9:40 am

Neoprobe Corporation (NEOP.OB) Receives $3 Million in Clinical Funding

Neoprobe Corporation, a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, has completed the second closing of $3 million in financing. This funding will help Neoprobe start its Phase 3 clinical studies of Lymphoseek in patients with breast cancer or melanoma and head and neck squamous cell carcinoma. Montaur issued the funds to Neoprobe in the form of a secured note. The note, which is fully convertible into Neoprobe common shares at $0.36 per share - the closing price of Neoprobe’s common stock on April 10, 2008 when the investment was priced - is repayable in December…

WednesdayApr 16, 2008 8:08 am

StockGuru Stocks to Watch for Wednesday, April 16, 2008 Featuring Euoko, Metro One Development, NextGen Bioscience, China Voice, and Sports Pouch Beverage

Euoko Group Inc. (OTCBB: EUOK) Euoko Group Inc. (OTCBB: EUOK) - Tuesday’s shares stayed even at $2.25. No shares were traded. Euoko, a luxury skin care brand owned by Euoko Group Inc.), announced April 15ththat it appointed Atout Cosmetics GmbH & CoKG as its exclusive distributor for Germany, Denmark, Switzerland, Belgium and the Netherlands. The terms of the agreement offer three years of exclusivity to Atout Cosmetics and allow for annual price adjustments. “We are excited to have partnered with Atout’s strong team to extend our distribution in these markets. The positive feedback we have received from these markets allow…

Site Search

Company Search